Research Catalog · peptide family
Amyloid Beta S26C Cross-Linked Dimers — Research Products
4 catalog items
| Catalog # | Product | Type | Species | Size | Price | Add to cart |
|---|---|---|---|---|---|---|
| G-018-71 | Amyloid beta 40-S26C dimer / [A-beta S26C]2 (Human) – Purified IgG Antibody | Antibodies | Human | 200 µg | $612.00 | |
| 018-71 | Amyloid beta 40-S26C dimer/ [A-beta 40 S26C]2 (Human) | Peptides | Human | 100 µg | $409.00 | |
| 018-92 | Amyloid beta-42 S26C dimer/ [A-beta 42 S26C]2 (Human) | Peptides | Human | 100 ug | $388.00 | |
| 018-94 | Amyloid beta-43 S26C dimer/ [A-beta 43 S26C]2 (Human) | Peptides | Human | 100 ug | $388.00 |
All items are supplied for in vitro laboratory research use only — not for human or veterinary use, diagnosis or therapy. Prices are per unit as listed; each catalog number ships with its Certificate of Analysis.
Amyloid Beta S26C Cross-Linked Dimers — frequently asked
What is an S26C amyloid beta dimer?
It is an engineered peptide in which serine 26 is replaced by cysteine, letting two chains be joined by a disulfide bond. The result is a covalent, defined dimer rather than a transient non-covalent assembly.
Why use cross-linked dimers instead of natural oligomers?
Naturally formed oligomers are heterogeneous and interconvert quickly, making experiments hard to reproduce. A covalently stabilised dimer provides a single defined species that can be prepared consistently and compared against monomer and fibril preparations.
Which sequence lengths are available?
Dimers based on the 40-, 42- and 43-residue amyloid beta sequences are supplied. Because C-terminal length strongly influences aggregation behaviour in reported studies, comparing dimers of different lengths is a common experimental design.